Beckman Coulter, Inc., based in California, USA, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 275,000 Beckman Coulter systems operate in both diagnostics and life sciences laboratories on six continents. Beckman Coulter Genomics has generated whole genome sequences for a variety of organisms with a wide range of associated genome sizes.

Factors considered for the best experimental design for a whole genome sequencing project include the size of the target genome, the anticipated complexity of the genome, the desired level of finishing, or completeness, and whether the genome requires de novo assembly or can be mapped against a published reference sequence.

Beckman Coulter Genomics, sets the standard for delivering expert genomics solutions to life science and healthcare businesses as well as academic and government institutions worldwide. By providing technical expertise, combined with personalized service, Beckman Coulter Genomics delivers the highest quality data, robust analyses and innovative thinking.

From classic to cutting-edge, Beckman Coulter Genomics has expertise and experience on a wide range of genomic technology platforms, including the Illumina* HiSeq* 2000, Roche* 454* GS FLX*, ABI* 3730XL and ABI 7900HT, and is dedicated to delivering the highest quality results. Services include next generation and Sanger sequencing, genotyping, expression analysis and biologics testing.